首页|新型冠状病毒感染人员核酸首次阳性和恢复期再次阳性病毒载量及抗体水平分析

新型冠状病毒感染人员核酸首次阳性和恢复期再次阳性病毒载量及抗体水平分析

扫码查看
目的 研究核酸首次阳性和核酸再次阳性的新型冠状病毒感染(corona virus disease 2019,COVID-19)人员的核酸及抗体变化特征.方法 采用化学发光法对一起新型冠状病毒感染暴发疫情中102名核酸再次阳性人员(再阳人员)、165名核酸首次阳性人员(首阳人员)恢复期的血清标本进行抗体检测,实时荧光RT-PCR方法检测病毒核酸,人员基本信息来自中国疾病预防控制信息系统-传染病信息报告管理系统,包括人口学特征、发病时间及核酸检测结果等.利用SPSS22.0对数据进行统计分析.结果 再阳人员的再阳间隔时间集中在31~60d(78.43%),<61岁者占89.22%.再阳人员ORF1ab基因和N基因的平均Ct值分别为34.99(33.63,36.87)和34.81±2.28,高于首阳人员的26.73(23.25,33.13)和27.67± 5.54,差异均有统计学意义(P<0.05).再阳人员的IgM、IgG抗体水平M(P25,P75)分别为0.32(0.01,1.09)、152.45(89.09,231.84),首阳人员分别为0.41(0.13,1.07)、134.85(65.03,245.36),再阳和首阳人员中和抗体水平M(P25,P75)分别为 3 157.87(1 635.99,3 550.26)、2874.61(1 158.57,3 791.64)AU/mL,差异均无统计学意义(P>0.05).结论 再阳人员和首阳人员恢复期的IgM、IgG和中和抗体水平无差异,再阳人员的病毒载量低于首阳人员,传染性较低.
Analysis of viral load and convalescent antibody levels between individuals of COVID-19 with initial positive and re-positive nucleic acid test during the recovery period
Objective To study the characteristics of nucleic acid and antibody changes in COVD-19 individuals with initial positive and re-positive nucleic acid test(NAT).Methods The serum samples of 102 individuals with re-positive NAT and 165 individuals with initial positive NAT in the recovery period of a novel coronavirus infection outbreak were detected by chemiluminescence method.Real-time fluorescent RT-PCR method was used to detect viral nucleic acid.The basic information of all individuals came from China Disease Prevention and Control Information System-Infectious Disease Information Reporting Management System,including demographic characteristics,onset time,NAT results,etc.Perform statistical analysis on the data using SPSS 22.0.Results The recovery interval time for the individuals with re-positive NAT was concentrated between 31 to 60 days(78.43%),with 89.22%of individuals aged<61 years old.The mean Ct values of ORFlab gene and N gene in re-positive NAT individuals were 34.99(33.63,36.87)and 34.81±2.28,respectively,which were higher than 26.73(23.25,33.13)and 27.67±5.54 in initial positive NAT individuals,and the differences were statistically significant(P<0.05).The IgM,IgG antibody levels M(P25,P75)of the individuals with re-positive NAT were 0.32(0.01,1.09),152.45(89.09,231.84),neutralizing antibody levels M(P25,P75)were 3 157.87(1 635.99,3 550.26)AU/mL,respectively.The IgM,IgG antibody levels M(P25,P75)of the individuals with initial positive NAT were 0.41(0.13,1.07),134.85(65.03,245.36),and neutralizing antibody levels M(P25,P75)were 2 874.61(115.57,371.64)AU/mL,respectively,and the differences were not statistically significant(P>0.05).Conclusions There were no significant differences in the levels of IgM,IgG and neutralizing antibody during the recovery period between the individuals with re-positive NAT and initial positive NAT.The viral load of re-positive NAT individuals is lower than initial positive NAT individuals,and the possibility of infection was relatively low.

COVID-19Re-positive nucleic acid testIgG antibodyIgM antibodyNeutralizing antibody

李东晓、胡晓、朱琳、李懿、李亚飞、宋云、卢世栋、马红霞、叶莹、黄学勇

展开 >

河南省疾病预防控制中心传染病预防控制所,河南省传染病病原生物重点实验室,河南郑州 450016

COVID-19 核酸再次阳性 IgG抗体 IgM抗体 中和抗体

河南省疫情防控应急科技攻关项目河南省科技攻关项目河南省中青年卫生健康科技创新领军人才培养项目

221111311300232102310281YXKC2020006

2024

河南预防医学杂志
河南省预防医学会

河南预防医学杂志

影响因子:0.409
ISSN:1006-8414
年,卷(期):2024.35(2)
  • 21